173 related articles for article (PubMed ID: 32133341)
1. Development of Relaxin-3 Agonists and Antagonists Based on Grafted Disulfide-Stabilized Scaffolds.
Lee HS; Postan M; Song A; Clark RJ; Bathgate RAD; Haugaard-Kedström LM; Rosengren KJ
Front Chem; 2020; 8():87. PubMed ID: 32133341
[TBL] [Abstract][Full Text] [Related]
2. Exploring the Use of Helicogenic Amino Acids for Optimising Single Chain Relaxin-3 Peptide Agonists.
Lee HS; Wang SH; Daniel JT; Hossain MA; Clark RJ; Bathgate RAD; Rosengren KJ
Biomedicines; 2020 Oct; 8(10):. PubMed ID: 33066369
[TBL] [Abstract][Full Text] [Related]
3. Distinct but overlapping binding sites of agonist and antagonist at the relaxin family peptide 3 (RXFP3) receptor.
Wong LLL; Scott DJ; Hossain MA; Kaas Q; Rosengren KJ; Bathgate RAD
J Biol Chem; 2018 Oct; 293(41):15777-15789. PubMed ID: 30131340
[TBL] [Abstract][Full Text] [Related]
4. Hydrocarbon stapled B chain analogues of relaxin-3 retain biological activity.
Jayakody T; Marwari S; Lakshminarayanan R; Tan FC; Johannes CW; Dymock BW; Poulsen A; Herr DR; Dawe GS
Peptides; 2016 Oct; 84():44-57. PubMed ID: 27498038
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of biased agonism by Gα
Jayakody T; Inoue A; Kannan S; Nakamura G; Kawakami K; Mendis K; Nguyen TB; Li J; Herr DR; Verma CS; Dawe GS
Sci Signal; 2024 Feb; 17(823):eabl5880. PubMed ID: 38349968
[TBL] [Abstract][Full Text] [Related]
6. Central injection of relaxin-3 receptor (RXFP3) antagonist peptides reduces motivated food seeking and consumption in C57BL/6J mice.
Smith CM; Chua BE; Zhang C; Walker AW; Haidar M; Hawkes D; Shabanpoor F; Hossain MA; Wade JD; Rosengren KJ; Gundlach AL
Behav Brain Res; 2014 Jul; 268():117-26. PubMed ID: 24681162
[TBL] [Abstract][Full Text] [Related]
7. Minimization of human relaxin-3 leading to high-affinity analogues with increased selectivity for relaxin-family peptide 3 receptor (RXFP3) over RXFP1.
Shabanpoor F; Akhter Hossain M; Ryan PJ; Belgi A; Layfield S; Kocan M; Zhang S; Samuel CS; Gundlach AL; Bathgate RA; Separovic F; Wade JD
J Med Chem; 2012 Feb; 55(4):1671-81. PubMed ID: 22257012
[TBL] [Abstract][Full Text] [Related]
8. Relaxin-3 receptor (Rxfp3) gene knockout mice display reduced running wheel activity: implications for role of relaxin-3/RXFP3 signalling in sustained arousal.
Hosken IT; Sutton SW; Smith CM; Gundlach AL
Behav Brain Res; 2015 Feb; 278():167-75. PubMed ID: 25257104
[TBL] [Abstract][Full Text] [Related]
9. Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7.
Liu C; Kuei C; Sutton S; Shelton J; Zhu J; Nepomuceno D; Hossain MA; Wade JD; Bathgate RA; Bonaventure P; Lovenberg T
Ann N Y Acad Sci; 2009 Apr; 1160():31-7. PubMed ID: 19416155
[TBL] [Abstract][Full Text] [Related]
10. Elucidation of relaxin-3 binding interactions in the extracellular loops of RXFP3.
Bathgate RA; Oh MH; Ling WJ; Kaas Q; Hossain MA; Gooley PR; Rosengren KJ
Front Endocrinol (Lausanne); 2013; 4():13. PubMed ID: 23440673
[TBL] [Abstract][Full Text] [Related]
11. Discovery and Characterization of the First Nonpeptide Antagonists for the Relaxin-3/RXFP3 System.
Gay EA; Guan D; Van Voorhies K; Vasukuttan V; Mathews KM; Besheer J; Jin C
J Med Chem; 2022 Jun; 65(11):7959-7974. PubMed ID: 35594150
[TBL] [Abstract][Full Text] [Related]
12. Hydrophobic interactions of relaxin family peptide receptor 3 with ligands identified using a NanoBiT-based binding assay.
Li HZ; Li N; Shao XX; Liu YL; Xu ZG; Guo ZY
Biochimie; 2020 Oct; 177():117-126. PubMed ID: 32810565
[TBL] [Abstract][Full Text] [Related]
13. Development of a selective agonist for relaxin family peptide receptor 3.
Wei D; Hu MJ; Shao XX; Wang JH; Nie WH; Liu YL; Xu ZG; Guo ZY
Sci Rep; 2017 Jun; 7(1):3230. PubMed ID: 28607363
[TBL] [Abstract][Full Text] [Related]
14. Identification of hydrophobic interactions between relaxin-3 and its receptor RXFP3: implication for a conformational change in the B-chain C-terminus during receptor binding.
Hu MJ; Shao XX; Wang JH; Wei D; Liu YL; Xu ZG; Guo ZY
Amino Acids; 2016 Sep; 48(9):2227-36. PubMed ID: 27193232
[TBL] [Abstract][Full Text] [Related]
15. Central relaxin-3 receptor (RXFP3) activation decreases anxiety- and depressive-like behaviours in the rat.
Ryan PJ; Büchler E; Shabanpoor F; Hossain MA; Wade JD; Lawrence AJ; Gundlach AL
Behav Brain Res; 2013 May; 244():142-51. PubMed ID: 23380674
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol modulates the binding properties of human relaxin family peptide receptor 3 with its ligands.
Wang JH; Hu MJ; Shao XX; Wei D; Liu YL; Xu ZG; Guo ZY
Arch Biochem Biophys; 2018 May; 646():24-30. PubMed ID: 29601823
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of relaxin-3 and a selective relaxin-3 receptor agonist on food and water intake and hypothalamic neuronal activity in rats.
de Ávila C; Chometton S; Lenglos C; Calvez J; Gundlach AL; Timofeeva E
Behav Brain Res; 2018 Jan; 336():135-144. PubMed ID: 28864207
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological activation of RXFP3 is not orexigenic in C57BL/6J mice.
Smith CM; Hosken IT; Downer NL; Chua BE; Hossain MA; Wade JD; Gundlach AL
Ital J Anat Embryol; 2013; 118(1 Suppl):52-5. PubMed ID: 24640572
[TBL] [Abstract][Full Text] [Related]
19. The structural and functional role of the B-chain C-terminal arginine in the relaxin-3 peptide antagonist, R3(BDelta23-27)R/I5.
Hossain MA; Bathgate RA; Rosengren KJ; Shabanpoor F; Zhang S; Lin F; Tregear GW; Wade JD
Chem Biol Drug Des; 2009 Jan; 73(1):46-52. PubMed ID: 19152634
[TBL] [Abstract][Full Text] [Related]
20. Mechanism for insulin-like peptide 5 distinguishing the homologous relaxin family peptide receptor 3 and 4.
Hu MJ; Shao XX; Wang JH; Wei D; Guo YQ; Liu YL; Xu ZG; Guo ZY
Sci Rep; 2016 Jul; 6():29648. PubMed ID: 27404393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
